Mohammed Abdelfatah Ibrahim

Hamad General Hospital

Papers

1

Total Citations

6

H-Index

1

About

Dr. Mohammed Abdelfatah Ibrahim is a pioneering urological surgeon whose research centers on advancing minimally invasive treatments for kidney stone disease, with a particular focus on robotic-assisted techniques. He is best known for conceptualizing the "tetrafecta" outcome metric for robotic flexible ureteroscopy (RFURS), a comprehensive framework that goes beyond traditional stone-free rates to include complication avoidance, operative efficiency, and functional recovery. His seminal 2024 paper introducing this paradigm has already garnered 6 citations, signaling its rapid adoption as a new standard for reporting surgical success in endourology. Dr. Ibrahim’s work directly addresses the critical need for standardized, patient-centered outcome measures in robotic stone surgery, helping clinicians better evaluate and compare treatment approaches. By demonstrating that RFURS can achieve superior ergonomics and clinical results, his research is shaping the next generation of kidney stone management. His contributions are particularly impactful for young surgeons and researchers seeking to understand how robotic platforms can optimize both technical performance and patient quality of life, establishing him as an emerging thought leader in the field of robotic endourology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Optimizing outcome reporting after robotic flexible ureteroscopy for management of renal calculi: Introducing the concept of tetrafecta
6 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Hamad General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago